Dr. Aruna Railkar.jpg

Dr. Aruna Railkar

Former Quotient Sciences Colleague

Subject Expert
About

Dr. Aruna Railkar has more than two decades of experience in the pharmaceutical industry and in the areas of NCE screening, compound characterization, and formulation development. Aruna's areas of interest extend to the formulation development of new chemical entities, controlled release for solid oral dosage forms and injectable dosage forms, targeted drug delivery, prodrugs, and solubility enhancement of low-solubility compounds.

Prior to joining Quotient Sciences, Aruna worked at Kashiv BioSciences in the areas of drug delivery and formulation development, and in various roles with Roche, most recently as a Senior Research Leader. 

Aruna holds a Ph.D. in pharmaceutical sciences from West Virginia University and post-doctoral studies completed in pharmaceutical sciences at the University of Minnesota.

Quotient Sciences Logo
Translational Pharmaceutics, Drug Product Optimization, Dr. Aruna Railkar

How Translational Pharmaceutics® Supports Drug Product Optimization (Video)

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More